These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1967830)

  • 1. Application of entropy measures derived from the ergodic theory of dynamical systems to rat locomotor behavior.
    Paulus MP; Geyer MA; Gold LH; Mandell AJ
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):723-7. PubMed ID: 1967830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity.
    Paulus MP; Geyer MA
    Neuropsychopharmacology; 1992 Aug; 7(1):15-31. PubMed ID: 1355968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.
    Spanos LJ; Yamamoto BK
    Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral suppression following 3,4-methylenenedioxymethamphetamine.
    Kulmala HK; Boja JW; Schechter MD
    Life Sci; 1987 Sep; 41(11):1425-9. PubMed ID: 2887995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of conditioned taste aversions produced by MDMA and d-amphetamine.
    Lin HQ; Atrens DM; Christie MJ; Jackson DM; McGregor IS
    Pharmacol Biochem Behav; 1993 Sep; 46(1):153-6. PubMed ID: 7902981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G; Sharkey J; Kuhar MJ; de Souza EB
    Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
    Gold LH; Koob GF; Geyer MA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):547-55. PubMed ID: 2903234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.
    Callaway CW; Rempel N; Peng RY; Geyer MA
    Neuropsychopharmacology; 1992 Sep; 7(2):113-27. PubMed ID: 1358088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
    Callaway CW; Geyer MA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):318-26. PubMed ID: 1357158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve alpha-adrenoceptors.
    Bexis S; Docherty JR
    Br J Pharmacol; 2006 Apr; 147(8):926-34. PubMed ID: 16491100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychostimulant properties of MDMA.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 95():345-6. PubMed ID: 2577038
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC; Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
    Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT; Insel TR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):212-20. PubMed ID: 1973197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Morley KC; Cornish JL; Li KM; McGregor IS
    Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
    Fletcher PJ; Korth KM; Robinson SR; Baker GB
    Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.